Brendan Haberle

Associate
Full contact info

Experience

Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca

January 2, 2024

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Brendan Haberle
Associate, San Diego
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Jameson Davis
Associate, Palo Alto
Xander Lee
Partner, Los Angeles Santa Monica
Mor Agam
Associate, New York
Sharon Connaughton
Special Counsel, Washington, DC
Rachel Thorn
Partner, New York
Elizabeth Anne Wright
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Jessica Koffel
Associate, Brussels
Robert Eisenbach
Of Counsel, San Francisco

Related Practices & Industries

Cooley Supports Jiangsu Hengrui in Two Global License Agreements

November 8, 2023

Cooley advised Jiangsu Hengrui Pharmaceuticals, a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing and commercialization of innovative and high-quality healthcare products, on its strategic collaboration and exclusive worldwide (excluding mainland China) license agreement with Merck KGaA, Darmstadt, Germany and global license agreement (excluding the Greater China region and Korea) with Elevar Therapeutics.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Freddy Yip
Associate, Hong Kong
Alan W. Tamarelli
Partner, New York
Bin Wang
Special Counsel, Palo Alto
Bill Christiansen
Partner, Seattle
Dr. Xixi Sun
Associate, Boston
Amanda Pacheco
Associate, Palo Alto
Brendan Haberle
Associate, San Diego
Howard Morse
Partner, Washington, DC

Related Practices & Industries

Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche

August 6, 2022

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its strategic collaboration and license agreement with Roche. Lawyers Ken Krisko, Marya Postner, Bin Wang, Hajra Nashin and Brendan Haberle led the Cooley team advising Poseida. 

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Marya Postner
Partner, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Brendan Haberle
Associate, San Diego
Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
Sharon Connaughton
Special Counsel, Washington, DC
Jacqueline Grise
Partner, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Jeffrey J. Tolin
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Liza Cotter
Associate, Boston
Yasmin Roland
Associate, Brussels
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Maricel Mojares-Moore
Special Counsel, San Francisco

Related Practices & Industries

Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion

June 4, 2022

Cooley is advising Turning Point Therapeutics, a leading precision oncology company, on its definitive agreement to be acquired by global biopharmaceutical company Bristol Myers Squibb. Lawyers Barbara Borden, Rowook Park, Charles Bair, Lindsey O’Crump, Vivian Tsai and Melissa Meza are leading the Cooley team advising Turning Point Therapeutics.

Read more

Related contacts

Barbara Borden
Partner, San Diego
Rowook Park
Partner, San Diego
Charles Bair
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Melissa Meza
Associate, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Koji Fukumura
Partner, San Diego
Phil Mitchell
Partner, New York
David Navetta
Partner, Colorado
Todd Gluth
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Matthew D. Silverman
Special Counsel, San Diego
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Brendan Haberle
Associate, San Diego
Megan Drill
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Eileen Leman
Associate, Los Angeles Downtown
Daniel Gillon
Associate, San Diego
Wade Andrews
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Jennifer Shanley
Special Counsel, New York
Daniel Lac
Associate, San Diego

Related Practices & Industries

Poseida Therapeutics Enters Research Collaboration With Takeda to Develop Novel Gene Therapies

November 17, 2021

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its research collaboration and exclusive license agreement with Takeda Pharmaceutical Co. Lawyers Ken Krisko and Brendan Haberle led the Cooley team advising Poseida.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Brendan Haberle
Associate, San Diego
Jacqueline Grise
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Edmond Lay
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

View more